Entry Point Capital, LLC Fulgent Genetics, Inc. Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 15,622 shares of FLGT stock, worth $355,712. This represents 0.3% of its overall portfolio holdings.
Number of Shares
15,622
Previous 103
15066.99%
Holding current value
$355,712
Previous $2.98 Million
11283.38%
% of portfolio
0.3%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FLGT
# of Institutions
198Shares Held
14.7MCall Options Held
1.16MPut Options Held
92.9K-
Black Rock Inc. New York, NY3.92MShares$89.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$32.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.35MShares$30.6 Million0.01% of portfolio
-
State Street Corp Boston, MA824KShares$18.8 Million0.0% of portfolio
-
Park West Asset Management LLC Larkspur, CA730KShares$16.6 Million1.15% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $689M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...